Literature DB >> 21935715

Valuing EQ-5D using time trade-off in France.

Julie Chevalier1, Gérard de Pouvourville.   

Abstract

OBJECTIVES: While a French language version of the EQ-5D exists, to date, there has been no French value set to accompany it. The objective of our study was then to derive the French TTO value set of the EQ-5D.
METHODS: A total of 452 respondents aged over 18 were recruited who were representative of the French population with regard to age, gender, and socio-professional group. The direct valuation of 24 health states was first obtained by Time Trade-Off (TTO), and the negative TTO values were bounded using the monotonic transformation. Several alternative model specifications were investigated to estimate the values for all 243 states in the EQ-5D descriptive system. Only the best fitting model is presented in this paper. The analysis was conducted at an individual level to make the maximum use of the available data, and we estimated mixed models with random intercept. Models were compared through the Akaike information criterion (AIC), the mean absolute error (MAE), and the Pearson correlation coefficient between the observed and the predicted values of each model.
RESULTS: After exclusion, 443 respondents took part in the study. The best fitting model included the same variables as the N3-model used in UK.
CONCLUSION: This study provides the French value set of the EQ-5D based on the stated preferences of the French general public facilitating cost-effectiveness analysis.

Mesh:

Year:  2011        PMID: 21935715     DOI: 10.1007/s10198-011-0351-x

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN: 1618-7598


  14 in total

1.  Comparison of Finnish and U.S.-based visual analog scale valuations of the EQ-5D measure.

Authors:  J A Johnson; A Ohinmaa; B Murti; H Sintonen; S J Coons
Journal:  Med Decis Making       Date:  2000 Jul-Sep       Impact factor: 2.583

2.  Estimating an EQ-5D population value set: the case of Japan.

Authors:  Aki Tsuchiya; Shunya Ikeda; Naoki Ikegami; Shuzo Nishimura; Ikuro Sakai; Takashi Fukuda; Chisato Hamashima; Akinori Hisashige; Makoto Tamura
Journal:  Health Econ       Date:  2002-06       Impact factor: 3.046

Review 3.  Statistical versus quantitative significance in the socioeconomic evaluation of medicines.

Authors:  B J O'Brien; M F Drummond
Journal:  Pharmacoeconomics       Date:  1994-05       Impact factor: 4.981

Review 4.  EuroQol: the current state of play.

Authors:  R Brooks
Journal:  Health Policy       Date:  1996-07       Impact factor: 2.980

5.  The effect of health state selection on the valuation of EQ-5D.

Authors:  Ling-Hsiang Chuang; Paul Kind
Journal:  Med Decis Making       Date:  2010-07-29       Impact factor: 2.583

6.  US valuation of the EQ-5D health states: development and testing of the D1 valuation model.

Authors:  James W Shaw; Jeffrey A Johnson; Stephen Joel Coons
Journal:  Med Care       Date:  2005-03       Impact factor: 2.983

7.  Valuations of EQ-5D health states: are the United States and United Kingdom different?

Authors:  Jeffrey A Johnson; Nan Luo; James W Shaw; Paul Kind; Stephen Joel Coons
Journal:  Med Care       Date:  2005-03       Impact factor: 2.983

8.  Valuation of EQ-5D health states in Poland: first TTO-based social value set in Central and Eastern Europe.

Authors:  Dominik Golicki; Michał Jakubczyk; Maciej Niewada; Witold Wrona; Jan J V Busschbach
Journal:  Value Health       Date:  2009-09-10       Impact factor: 5.725

9.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

10.  Modeling valuations for EuroQol health states.

Authors:  P Dolan
Journal:  Med Care       Date:  1997-11       Impact factor: 2.983

View more
  54 in total

1.  Time trade-off and attitudes toward euthanasia: implications of using 'death' as an anchor in health state valuation.

Authors:  Liv A Augestad; Kim Rand-Hendriksen; Knut Stavem; Ivar Sønbø Kristiansen
Journal:  Qual Life Res       Date:  2012-06-08       Impact factor: 4.147

2.  Impact of country-specific EQ-5D-3L tariffs on the economic value of systemic therapies used in the treatment of metastatic pancreatic cancer.

Authors:  K Lien; V C Tam; Y J Ko; N Mittmann; M C Cheung; K K W Chan
Journal:  Curr Oncol       Date:  2015-12       Impact factor: 3.677

3.  The valuation of the EQ-5D in Portugal.

Authors:  Lara N Ferreira; Pedro L Ferreira; Luis N Pereira; Mark Oppe
Journal:  Qual Life Res       Date:  2013-06-08       Impact factor: 4.147

4.  Using the EuroQol EQ-5D in Swiss cancer patients, which value set should be applied?

Authors:  Klazien Matter-Walstra; Dirk Klingbiel; Thomas Szucs; Bernhard C Pestalozzi; Matthias Schwenkglenks
Journal:  Pharmacoeconomics       Date:  2014-06       Impact factor: 4.981

Review 5.  Between-country heterogeneity in EQ-5D-3L scoring algorithms: how much is due to differences in health state selection?

Authors:  Eleanor M Pullenayegum; Kuhan Perampaladas; Kathryn Gaebel; Brett Doble; Feng Xie
Journal:  Eur J Health Econ       Date:  2014-09-25

6.  A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set.

Authors:  Pedro L Ferreira; Patrícia Antunes; Lara N Ferreira; Luís N Pereira; Juan M Ramos-Goñi
Journal:  Qual Life Res       Date:  2019-06-14       Impact factor: 4.147

7.  Sample size determination for EQ-5D-5L value set studies.

Authors:  Mihir Gandhi; Ying Xu; Nan Luo; Yin Bun Cheung
Journal:  Qual Life Res       Date:  2017-08-19       Impact factor: 4.147

8.  Health state utility and quality of life measures in patients with chronic myeloid leukemia in France.

Authors:  Foulon S; Cony-Makhoul P; Guerci-Bresler A; Daban M; Kapso R; Tubert-Bitter P; Bonastre J
Journal:  Qual Life Res       Date:  2021-03-02       Impact factor: 4.147

9.  EQ-5D Portuguese population norms.

Authors:  Lara Noronha Ferreira; Pedro L Ferreira; Luis N Pereira; Mark Oppe
Journal:  Qual Life Res       Date:  2013-08-03       Impact factor: 4.147

10.  The impact of low back pain on health-related quality of life in old age: results from a survey of a large sample of Swiss elders living in the community.

Authors:  C Ludwig; C Luthy; A F Allaz; F R Herrmann; C Cedraschi
Journal:  Eur Spine J       Date:  2017-12-15       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.